Individualized resuscitation strategy for septic shock formalized by finite mixture modeling and dynamic treatment regimen
Background Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify subclasses of septic shock with non-supervised learning algorithms, so as to tailor resuscitation strategy for each class. Methods Patients with...
Saved in:
Published in | Critical care (London, England) Vol. 25; no. 1; pp. 1 - 16 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central Ltd
12.07.2021
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify subclasses of septic shock with non-supervised learning algorithms, so as to tailor resuscitation strategy for each class. Methods Patients with septic shock in 25 tertiary care teaching hospitals in China from January 2016 to December 2017 were enrolled in the study. Clinical and laboratory variables were collected on days 0, 1, 2, 3 and 7 after ICU admission. Subclasses of septic shock were identified by both finite mixture modeling and K-means clustering. Individualized fluid volume and norepinephrine dose were estimated using dynamic treatment regime (DTR) model to optimize the final mortality outcome. DTR models were validated in the eICU Collaborative Research Database (eICU-CRD) dataset. Results A total of 1437 patients with a mortality rate of 29% were included for analysis. The finite mixture modeling and K-means clustering robustly identified five classes of septic shock. Class 1 (baseline class) accounted for the majority of patients over all days; class 2 (critical class) had the highest severity of illness; class 3 (renal dysfunction) was characterized by renal dysfunction; class 4 (respiratory failure class) was characterized by respiratory failure; and class 5 (mild class) was characterized by the lowest mortality rate (21%). The optimal fluid infusion followed the resuscitation/de-resuscitation phases with initial large volume infusion and late restricted volume infusion. While class 1 transitioned to de-resuscitation phase on day 3, class 3 transitioned on day 1. Classes 1 and 3 might benefit from early use of norepinephrine, and class 2 can benefit from delayed use of norepinephrine while waiting for adequate fluid infusion. Conclusions Septic shock comprises a heterogeneous population that can be robustly classified into five phenotypes. These classes can be easily identified with routine clinical variables and can help to tailor resuscitation strategy in the context of precise medicine. Keywords: Sepsis, Dynamic treatment regime, Mortality, Fluid resuscitation |
---|---|
AbstractList | Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify subclasses of septic shock with non-supervised learning algorithms, so as to tailor resuscitation strategy for each class.BACKGROUNDSeptic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify subclasses of septic shock with non-supervised learning algorithms, so as to tailor resuscitation strategy for each class.Patients with septic shock in 25 tertiary care teaching hospitals in China from January 2016 to December 2017 were enrolled in the study. Clinical and laboratory variables were collected on days 0, 1, 2, 3 and 7 after ICU admission. Subclasses of septic shock were identified by both finite mixture modeling and K-means clustering. Individualized fluid volume and norepinephrine dose were estimated using dynamic treatment regime (DTR) model to optimize the final mortality outcome. DTR models were validated in the eICU Collaborative Research Database (eICU-CRD) dataset.METHODSPatients with septic shock in 25 tertiary care teaching hospitals in China from January 2016 to December 2017 were enrolled in the study. Clinical and laboratory variables were collected on days 0, 1, 2, 3 and 7 after ICU admission. Subclasses of septic shock were identified by both finite mixture modeling and K-means clustering. Individualized fluid volume and norepinephrine dose were estimated using dynamic treatment regime (DTR) model to optimize the final mortality outcome. DTR models were validated in the eICU Collaborative Research Database (eICU-CRD) dataset.A total of 1437 patients with a mortality rate of 29% were included for analysis. The finite mixture modeling and K-means clustering robustly identified five classes of septic shock. Class 1 (baseline class) accounted for the majority of patients over all days; class 2 (critical class) had the highest severity of illness; class 3 (renal dysfunction) was characterized by renal dysfunction; class 4 (respiratory failure class) was characterized by respiratory failure; and class 5 (mild class) was characterized by the lowest mortality rate (21%). The optimal fluid infusion followed the resuscitation/de-resuscitation phases with initial large volume infusion and late restricted volume infusion. While class 1 transitioned to de-resuscitation phase on day 3, class 3 transitioned on day 1. Classes 1 and 3 might benefit from early use of norepinephrine, and class 2 can benefit from delayed use of norepinephrine while waiting for adequate fluid infusion.RESULTSA total of 1437 patients with a mortality rate of 29% were included for analysis. The finite mixture modeling and K-means clustering robustly identified five classes of septic shock. Class 1 (baseline class) accounted for the majority of patients over all days; class 2 (critical class) had the highest severity of illness; class 3 (renal dysfunction) was characterized by renal dysfunction; class 4 (respiratory failure class) was characterized by respiratory failure; and class 5 (mild class) was characterized by the lowest mortality rate (21%). The optimal fluid infusion followed the resuscitation/de-resuscitation phases with initial large volume infusion and late restricted volume infusion. While class 1 transitioned to de-resuscitation phase on day 3, class 3 transitioned on day 1. Classes 1 and 3 might benefit from early use of norepinephrine, and class 2 can benefit from delayed use of norepinephrine while waiting for adequate fluid infusion.Septic shock comprises a heterogeneous population that can be robustly classified into five phenotypes. These classes can be easily identified with routine clinical variables and can help to tailor resuscitation strategy in the context of precise medicine.CONCLUSIONSSeptic shock comprises a heterogeneous population that can be robustly classified into five phenotypes. These classes can be easily identified with routine clinical variables and can help to tailor resuscitation strategy in the context of precise medicine. Background Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify subclasses of septic shock with non-supervised learning algorithms, so as to tailor resuscitation strategy for each class. Methods Patients with septic shock in 25 tertiary care teaching hospitals in China from January 2016 to December 2017 were enrolled in the study. Clinical and laboratory variables were collected on days 0, 1, 2, 3 and 7 after ICU admission. Subclasses of septic shock were identified by both finite mixture modeling and K-means clustering. Individualized fluid volume and norepinephrine dose were estimated using dynamic treatment regime (DTR) model to optimize the final mortality outcome. DTR models were validated in the eICU Collaborative Research Database (eICU-CRD) dataset. Results A total of 1437 patients with a mortality rate of 29% were included for analysis. The finite mixture modeling and K-means clustering robustly identified five classes of septic shock. Class 1 (baseline class) accounted for the majority of patients over all days; class 2 (critical class) had the highest severity of illness; class 3 (renal dysfunction) was characterized by renal dysfunction; class 4 (respiratory failure class) was characterized by respiratory failure; and class 5 (mild class) was characterized by the lowest mortality rate (21%). The optimal fluid infusion followed the resuscitation/de-resuscitation phases with initial large volume infusion and late restricted volume infusion. While class 1 transitioned to de-resuscitation phase on day 3, class 3 transitioned on day 1. Classes 1 and 3 might benefit from early use of norepinephrine, and class 2 can benefit from delayed use of norepinephrine while waiting for adequate fluid infusion. Conclusions Septic shock comprises a heterogeneous population that can be robustly classified into five phenotypes. These classes can be easily identified with routine clinical variables and can help to tailor resuscitation strategy in the context of precise medicine. Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify subclasses of septic shock with non-supervised learning algorithms, so as to tailor resuscitation strategy for each class. A total of 1437 patients with a mortality rate of 29% were included for analysis. The finite mixture modeling and K-means clustering robustly identified five classes of septic shock. Class 1 (baseline class) accounted for the majority of patients over all days; class 2 (critical class) had the highest severity of illness; class 3 (renal dysfunction) was characterized by renal dysfunction; class 4 (respiratory failure class) was characterized by respiratory failure; and class 5 (mild class) was characterized by the lowest mortality rate (21%). The optimal fluid infusion followed the resuscitation/de-resuscitation phases with initial large volume infusion and late restricted volume infusion. While class 1 transitioned to de-resuscitation phase on day 3, class 3 transitioned on day 1. Classes 1 and 3 might benefit from early use of norepinephrine, and class 2 can benefit from delayed use of norepinephrine while waiting for adequate fluid infusion. Septic shock comprises a heterogeneous population that can be robustly classified into five phenotypes. These classes can be easily identified with routine clinical variables and can help to tailor resuscitation strategy in the context of precise medicine. Background Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify subclasses of septic shock with non-supervised learning algorithms, so as to tailor resuscitation strategy for each class. Methods Patients with septic shock in 25 tertiary care teaching hospitals in China from January 2016 to December 2017 were enrolled in the study. Clinical and laboratory variables were collected on days 0, 1, 2, 3 and 7 after ICU admission. Subclasses of septic shock were identified by both finite mixture modeling and K-means clustering. Individualized fluid volume and norepinephrine dose were estimated using dynamic treatment regime (DTR) model to optimize the final mortality outcome. DTR models were validated in the eICU Collaborative Research Database (eICU-CRD) dataset. Results A total of 1437 patients with a mortality rate of 29% were included for analysis. The finite mixture modeling and K-means clustering robustly identified five classes of septic shock. Class 1 (baseline class) accounted for the majority of patients over all days; class 2 (critical class) had the highest severity of illness; class 3 (renal dysfunction) was characterized by renal dysfunction; class 4 (respiratory failure class) was characterized by respiratory failure; and class 5 (mild class) was characterized by the lowest mortality rate (21%). The optimal fluid infusion followed the resuscitation/de-resuscitation phases with initial large volume infusion and late restricted volume infusion. While class 1 transitioned to de-resuscitation phase on day 3, class 3 transitioned on day 1. Classes 1 and 3 might benefit from early use of norepinephrine, and class 2 can benefit from delayed use of norepinephrine while waiting for adequate fluid infusion. Conclusions Septic shock comprises a heterogeneous population that can be robustly classified into five phenotypes. These classes can be easily identified with routine clinical variables and can help to tailor resuscitation strategy in the context of precise medicine. Keywords: Sepsis, Dynamic treatment regime, Mortality, Fluid resuscitation Abstract Background Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify subclasses of septic shock with non-supervised learning algorithms, so as to tailor resuscitation strategy for each class. Methods Patients with septic shock in 25 tertiary care teaching hospitals in China from January 2016 to December 2017 were enrolled in the study. Clinical and laboratory variables were collected on days 0, 1, 2, 3 and 7 after ICU admission. Subclasses of septic shock were identified by both finite mixture modeling and K-means clustering. Individualized fluid volume and norepinephrine dose were estimated using dynamic treatment regime (DTR) model to optimize the final mortality outcome. DTR models were validated in the eICU Collaborative Research Database (eICU-CRD) dataset. Results A total of 1437 patients with a mortality rate of 29% were included for analysis. The finite mixture modeling and K-means clustering robustly identified five classes of septic shock. Class 1 (baseline class) accounted for the majority of patients over all days; class 2 (critical class) had the highest severity of illness; class 3 (renal dysfunction) was characterized by renal dysfunction; class 4 (respiratory failure class) was characterized by respiratory failure; and class 5 (mild class) was characterized by the lowest mortality rate (21%). The optimal fluid infusion followed the resuscitation/de-resuscitation phases with initial large volume infusion and late restricted volume infusion. While class 1 transitioned to de-resuscitation phase on day 3, class 3 transitioned on day 1. Classes 1 and 3 might benefit from early use of norepinephrine, and class 2 can benefit from delayed use of norepinephrine while waiting for adequate fluid infusion. Conclusions Septic shock comprises a heterogeneous population that can be robustly classified into five phenotypes. These classes can be easily identified with routine clinical variables and can help to tailor resuscitation strategy in the context of precise medicine. |
ArticleNumber | 243 |
Audience | Academic |
Author | Zhang, Jicheng Peng, Yue Li, Zhenliang Duan, Meili Zhou, Feihu Kang, Yan Qian, Kejian Ma, Penglin Liao, Xuelian Ma, Wenjing Wang, Jingwen Wang, ZongYu Han, Jianwei Wang, Peng Liu, Jingtao Li, Tong Xin, Xin Wan, Xianyao Deng, Qun Zhao, Mingyan Shen, Feng Xie, Jing Zhao, Heling Huang, Man Zhang, Zhongheng Li, Shusheng Xiu, Ming Zhu, Yue Ding, Guolei |
Author_xml | – sequence: 1 givenname: Penglin surname: Ma fullname: Ma, Penglin – sequence: 2 givenname: Jingtao surname: Liu fullname: Liu, Jingtao – sequence: 3 givenname: Feng surname: Shen fullname: Shen, Feng – sequence: 4 givenname: Xuelian surname: Liao fullname: Liao, Xuelian – sequence: 5 givenname: Ming surname: Xiu fullname: Xiu, Ming – sequence: 6 givenname: Heling surname: Zhao fullname: Zhao, Heling – sequence: 7 givenname: Mingyan surname: Zhao fullname: Zhao, Mingyan – sequence: 8 givenname: Jing surname: Xie fullname: Xie, Jing – sequence: 9 givenname: Peng surname: Wang fullname: Wang, Peng – sequence: 10 givenname: Man surname: Huang fullname: Huang, Man – sequence: 11 givenname: Tong surname: Li fullname: Li, Tong – sequence: 12 givenname: Meili surname: Duan fullname: Duan, Meili – sequence: 13 givenname: Kejian surname: Qian fullname: Qian, Kejian – sequence: 14 givenname: Yue surname: Peng fullname: Peng, Yue – sequence: 15 givenname: Feihu surname: Zhou fullname: Zhou, Feihu – sequence: 16 givenname: Xin surname: Xin fullname: Xin, Xin – sequence: 17 givenname: Xianyao surname: Wan fullname: Wan, Xianyao – sequence: 18 givenname: ZongYu surname: Wang fullname: Wang, ZongYu – sequence: 19 givenname: Shusheng surname: Li fullname: Li, Shusheng – sequence: 20 givenname: Jianwei surname: Han fullname: Han, Jianwei – sequence: 21 givenname: Zhenliang surname: Li fullname: Li, Zhenliang – sequence: 22 givenname: Guolei surname: Ding fullname: Ding, Guolei – sequence: 23 givenname: Qun surname: Deng fullname: Deng, Qun – sequence: 24 givenname: Jicheng surname: Zhang fullname: Zhang, Jicheng – sequence: 25 givenname: Yue surname: Zhu fullname: Zhu, Yue – sequence: 26 givenname: Wenjing surname: Ma fullname: Ma, Wenjing – sequence: 27 givenname: Jingwen surname: Wang fullname: Wang, Jingwen – sequence: 28 givenname: Yan surname: Kang fullname: Kang, Yan – sequence: 29 givenname: Zhongheng orcidid: 0000-0002-2336-5323 surname: Zhang fullname: Zhang, Zhongheng |
BookMark | eNp9Uklv1DAUjlARXeAPcIrEhUuKl9hxLkhVBXSkSlzgbHm8pB4Se7CdqtNfz5ulwFQI-WDrvW_xs7_z6iTEYKvqLUaXGAv-IWOKWNsgghtEuSBN96I6w5S3jWCUnfx1Pq3Oc14hhDvB6avqlLaEUULEWfW4CMbfezOr0T9aUyeb56x9UcXHUOeSVLHDpnYx1dmui9d1vov6x7YwHShLaPvgi60n_1DmBHs0dvRhqFUwtdkENQGvJKvKZEMBj8HD4XX10qkx2zeH_aL6_vnTt-ub5vbrl8X11W2jWYtKg_uO95TB1TE1qGtVKyznjgvO2g4zofmyx653VhGHW4cMM0hj0YuOoSWlll5Ui72uiWol18lPKm1kVF7uCjENUiWYbLQSqV4whrUjiLRcG_DgCCGBCNfCtT1ofdxrreflZI2GcZIaj0SPO8HfySHeS0E62vcYBN4fBFL8Odtc5OSztuOogo1zlgTsCUZ85_XuGXQV5xTgqbYo0vV9R8gf1KBgAB9cBF-9FZVXvCMUItByQF3-AwXLWPgbiJXzUD8ikD1Bp5hzsu73jBjJbfrkPn0S0id36ZMdkMQz0lOSwM2P_6P-Ah3y3q0 |
CitedBy_id | crossref_primary_10_1007_s44231_022_00007_2 crossref_primary_10_3390_cells13050439 crossref_primary_10_17816_psaic1547 crossref_primary_10_3389_fmed_2021_809478 crossref_primary_10_3389_fmed_2023_1166896 crossref_primary_10_1186_s13613_025_01428_0 crossref_primary_10_4103_jtccm_JTCCM_D_21_00011 crossref_primary_10_3390_microorganisms11092165 crossref_primary_10_3389_fmed_2022_766447 crossref_primary_10_1038_s41746_023_00961_1 crossref_primary_10_1002_phar_2763 crossref_primary_10_1097_CCM_0000000000006100 crossref_primary_10_3390_medicina60111740 crossref_primary_10_4266_acc_000480 crossref_primary_10_1016_j_amjms_2024_11_010 crossref_primary_10_3389_fimmu_2025_1546474 crossref_primary_10_1097_MEJ_0000000000000893 crossref_primary_10_1155_2022_3893653 crossref_primary_10_1097_EC9_0000000000000033 crossref_primary_10_1186_s13054_022_04211_w crossref_primary_10_15360_1813_9779_2024_6_2470 crossref_primary_10_15441_ceem_23_117 crossref_primary_10_1038_s41746_022_00580_2 crossref_primary_10_1097_CCE_0000000000001027 crossref_primary_10_1016_j_heliyon_2024_e28520 crossref_primary_10_4274_balkanmedj_galenos_2023_2023_4_6 crossref_primary_10_1016_j_isci_2022_105301 crossref_primary_10_1038_s41746_022_00650_5 crossref_primary_10_3389_fcvm_2023_1200441 crossref_primary_10_5005_jp_journals_10071_24546 crossref_primary_10_3389_fmed_2022_942356 |
Cites_doi | 10.1097/EDE.0000000000000586 10.1016/j.jcrc.2019.11.004 10.1016/j.jcrc.2018.06.012 10.1186/s40560-020-00496-7 10.1186/s13054-016-1343-0 10.18637/jss.v061.i06 10.1186/s12887-018-1188-6 10.1097/01.CCM.0000298158.12101.41 10.1097/CCM.0000000000004476 10.1001/jama.2015.7885 10.1038/s41598-020-73014-2 10.1038/sdata.2018.178 10.1097/CCM.0000000000000520 10.1001/jama.2016.0287 10.7554/eLife.58142 10.1007/s00134-018-5367-6 10.3390/nu11122976 10.1016/j.jbi.2017.11.015 10.1093/bja/aeu300 10.1007/s12561-013-9097-6 10.1186/s13054-014-0532-y 10.1056/NEJMoa1500896 10.21037/atm.2019.06.75 10.1016/j.jcrc.2020.11.002 10.1186/s13054-020-03275-w 10.1111/biom.12306 10.21037/atm.2016.09.40 10.1002/emp2.12060 10.1038/s41591-018-0213-5 10.21037/atm.2017.09.39 10.1097/CCM.0b013e31825bc565 10.1186/s13054-018-2279-3 10.1007/s00134-012-2769-8 10.1097/CCM.0000000000003084 10.1097/CCM.0000000000004786 10.1097/CCM.0b013e31826ab377 10.1001/jama.2019.5791 10.18637/jss.v080.i02 10.1001/jama.2019.0071 10.1016/j.arcmed.2019.10.003 10.1080/01621459.2014.937488 10.1371/journal.pone.0168838 10.1145/2939672.2939785 10.1056/NEJMoa1401602 10.1111/jebm.12418 10.1056/NEJMoa1404380 10.1186/s12882-016-0323-6 10.1186/s13613-018-0402-x 10.1038/s41598-020-74906-z 10.1186/s13054-020-03204-x 10.1097/CCM.0000000000004610 10.1186/s13054-019-2411-z |
ContentType | Journal Article |
Copyright | COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021. The Author(s). The Author(s) 2021 |
Copyright_xml | – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021. The Author(s). – notice: The Author(s) 2021 |
DBID | AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s13054-021-03682-7 |
DatabaseName | CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College Coronavirus Research Database ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Proquest Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1364-8535 1366-609X 1466-609X |
EndPage | 16 |
ExternalDocumentID | oai_doaj_org_article_0a98551cf20246cd86560008026c8f49 PMC8273991 A672336446 10_1186_s13054_021_03682_7 |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: ; grantid: 81901929 – fundername: ; grantid: YLGX-ZZ-2020005 |
GroupedDBID | --- 0R~ 29F 2WC 4.4 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABUWG ACGFS ACJQM ADBBV ADUKV AEGXH AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK E3Z EBD EBLON EBS EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P OK1 PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ ROL RPM RSV SJN SMD SOJ SV3 TR2 U2A UKHRP WOQ YOC PMFND 3V. 7XB 8FK AZQEC COVID DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c540t-197693517813d074a48e66f686547158c6b91f9fea2f14f0d5d0c1898750b33e3 |
IEDL.DBID | 7X7 |
ISSN | 1364-8535 1466-609X |
IngestDate | Wed Aug 27 01:27:43 EDT 2025 Thu Aug 21 18:04:39 EDT 2025 Fri Jul 11 03:08:07 EDT 2025 Fri Jul 25 05:21:08 EDT 2025 Tue Jun 17 21:29:47 EDT 2025 Tue Jun 10 20:38:14 EDT 2025 Thu Apr 24 23:10:05 EDT 2025 Tue Jul 01 03:55:01 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c540t-197693517813d074a48e66f686547158c6b91f9fea2f14f0d5d0c1898750b33e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-2336-5323 |
OpenAccessLink | https://www.proquest.com/docview/2552799722?pq-origsite=%requestingapplication% |
PMID | 34253228 |
PQID | 2552799722 |
PQPubID | 44362 |
PageCount | 16 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_0a98551cf20246cd86560008026c8f49 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8273991 proquest_miscellaneous_2551210649 proquest_journals_2552799722 gale_infotracmisc_A672336446 gale_infotracacademiconefile_A672336446 crossref_primary_10_1186_s13054_021_03682_7 crossref_citationtrail_10_1186_s13054_021_03682_7 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-07-12 |
PublicationDateYYYYMMDD | 2021-07-12 |
PublicationDate_xml | – month: 07 year: 2021 text: 2021-07-12 day: 12 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | Critical care (London, England) |
PublicationYear | 2021 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | M Singer (3682_CR25) 2016; 315 DM Yealy (3682_CR2) 2014; 370 K Bouferrache (3682_CR7) 2012; 40 Z Zhang (3682_CR27) 2016; 4 SV Bhavani (3682_CR20) 2020; 48 LP Black (3682_CR54) 2020; 1 GA Ospina-Tascón (3682_CR3) 2019; 321 Z Zhang (3682_CR31) 2019; 7 SL Peake (3682_CR10) 2014; 371 B Gårdlund (3682_CR19) 2018; 47 KP Seitz (3682_CR45) 2020; 8 PR Mouncey (3682_CR11) 2015; 372 D Colon Hidalgo (3682_CR51) 2020; 55 Y-Q Zhao (3682_CR24) 2015; 110 MP Wallace (3682_CR39) 2017; 28 X Bai (3682_CR52) 2014; 18 3682_CR17 Y Liu (3682_CR32) 2017; 2017 MA Elbouhy (3682_CR55) 2019; 50 M Legrand (3682_CR9) 2016; 20 Z Zhang (3682_CR30) 2017; 5 W Alhazzani (3682_CR5) 2020; 44 TE Sweeney (3682_CR18) 2021; 49 M Jozwiak (3682_CR44) 2013; 41 ZA Puthucheary (3682_CR12) 2020; 24 J Waechter (3682_CR50) 2014; 42 MB Mayhew (3682_CR16) 2018; 78 CW Seymour (3682_CR1) 2015; 314 WY Kim (3682_CR13) 2019; 11 RP Dellinger (3682_CR4) 2008; 36 S Goradia (3682_CR26) 2021; 61 J Schulz (3682_CR34) 2020; 4 Z Zhang (3682_CR47) 2020; 13 TJ Pollard (3682_CR35) 2018; 5 F Díaz (3682_CR46) 2018; 18 Y Li (3682_CR53) 2020; 24 JK Barrett (3682_CR40) 2014; 6 MLNG Malbrain (3682_CR42) 2018; 8 3682_CR37 3682_CR36 Z Zhang (3682_CR23) 2020; 10 CW Seymour (3682_CR21) 2019; 321 MP Wallace (3682_CR33) 2017; 80 3682_CR6 Z Zhang (3682_CR14) 2018; 22 TE Sweeney (3682_CR15) 2018; 46 RJ Roberts (3682_CR49) 2020; 48 R Claure-Del Granado (3682_CR48) 2016; 17 EA Hoste (3682_CR43) 2014; 113 M Komorowski (3682_CR22) 2018; 24 Z Zhang (3682_CR8) 2019; 23 M Charrad (3682_CR29) 2014; 61 MP Wallace (3682_CR41) 2015; 71 3682_CR28 C Albert Vega (3682_CR38) 2020; 10 |
References_xml | – volume: 28 start-page: e18 year: 2017 ident: 3682_CR39 publication-title: Epidemiology doi: 10.1097/EDE.0000000000000586 – volume: 55 start-page: 145 year: 2020 ident: 3682_CR51 publication-title: J Crit Care doi: 10.1016/j.jcrc.2019.11.004 – volume: 47 start-page: 70 year: 2018 ident: 3682_CR19 publication-title: J Crit Care doi: 10.1016/j.jcrc.2018.06.012 – volume: 8 start-page: 78 year: 2020 ident: 3682_CR45 publication-title: J Intensive Care doi: 10.1186/s40560-020-00496-7 – volume: 20 start-page: 165 year: 2016 ident: 3682_CR9 publication-title: Crit Care doi: 10.1186/s13054-016-1343-0 – volume: 61 start-page: 1 issue: 6 year: 2014 ident: 3682_CR29 publication-title: J Stat Softw. doi: 10.18637/jss.v061.i06 – volume: 18 start-page: 207 year: 2018 ident: 3682_CR46 publication-title: BMC Pediatr doi: 10.1186/s12887-018-1188-6 – volume: 36 start-page: 296 year: 2008 ident: 3682_CR4 publication-title: Crit Care Med doi: 10.1097/01.CCM.0000298158.12101.41 – volume: 48 start-page: 1445 issue: 10 year: 2020 ident: 3682_CR49 publication-title: Crit Care Med. doi: 10.1097/CCM.0000000000004476 – volume: 314 start-page: 708 year: 2015 ident: 3682_CR1 publication-title: JAMA doi: 10.1001/jama.2015.7885 – volume: 10 start-page: 16136 year: 2020 ident: 3682_CR38 publication-title: Sci Rep doi: 10.1038/s41598-020-73014-2 – volume: 5 start-page: 180178 year: 2018 ident: 3682_CR35 publication-title: Sci Data doi: 10.1038/sdata.2018.178 – volume: 42 start-page: 2158 year: 2014 ident: 3682_CR50 publication-title: Crit Care Med doi: 10.1097/CCM.0000000000000520 – volume: 315 start-page: 801 year: 2016 ident: 3682_CR25 publication-title: JAMA doi: 10.1001/jama.2016.0287 – ident: 3682_CR17 doi: 10.7554/eLife.58142 – volume: 44 start-page: 1691 year: 2020 ident: 3682_CR5 publication-title: Intensive Care Med doi: 10.1007/s00134-018-5367-6 – volume: 11 start-page: 2976 year: 2019 ident: 3682_CR13 publication-title: Nutrients doi: 10.3390/nu11122976 – volume: 78 start-page: 33 year: 2018 ident: 3682_CR16 publication-title: J Biomed Inform doi: 10.1016/j.jbi.2017.11.015 – volume: 113 start-page: 740 year: 2014 ident: 3682_CR43 publication-title: Br J Anaesth doi: 10.1093/bja/aeu300 – volume: 6 start-page: 244 year: 2014 ident: 3682_CR40 publication-title: Stat Biosci doi: 10.1007/s12561-013-9097-6 – volume: 18 start-page: 1303 year: 2014 ident: 3682_CR52 publication-title: Crit Care doi: 10.1186/s13054-014-0532-y – volume: 372 start-page: 1301 year: 2015 ident: 3682_CR11 publication-title: N Engl J Med doi: 10.1056/NEJMoa1500896 – volume: 7 start-page: 345 year: 2019 ident: 3682_CR31 publication-title: Ann Transl Med. doi: 10.21037/atm.2019.06.75 – volume: 61 start-page: 233 year: 2021 ident: 3682_CR26 publication-title: J Crit Care doi: 10.1016/j.jcrc.2020.11.002 – volume: 24 start-page: 577 year: 2020 ident: 3682_CR12 publication-title: Crit Care doi: 10.1186/s13054-020-03275-w – volume: 71 start-page: 636 year: 2015 ident: 3682_CR41 publication-title: Biometrics doi: 10.1111/biom.12306 – volume: 4 start-page: 9 year: 2016 ident: 3682_CR27 publication-title: Ann Transl Med doi: 10.21037/atm.2016.09.40 – volume: 2017 start-page: 380 year: 2017 ident: 3682_CR32 publication-title: Healthc Inform – volume: 1 start-page: 222 year: 2020 ident: 3682_CR54 publication-title: J Am Coll Emerg Physicians Open. doi: 10.1002/emp2.12060 – volume: 24 start-page: 1716 year: 2018 ident: 3682_CR22 publication-title: Nat Med doi: 10.1038/s41591-018-0213-5 – volume: 5 start-page: 484 year: 2017 ident: 3682_CR30 publication-title: Ann Transl Med doi: 10.21037/atm.2017.09.39 – volume: 40 start-page: 2821 year: 2012 ident: 3682_CR7 publication-title: Crit Care Med doi: 10.1097/CCM.0b013e31825bc565 – volume: 22 start-page: 347 year: 2018 ident: 3682_CR14 publication-title: Crit Care doi: 10.1186/s13054-018-2279-3 – ident: 3682_CR6 doi: 10.1007/s00134-012-2769-8 – volume: 46 start-page: 915 issue: 6 year: 2018 ident: 3682_CR15 publication-title: Crit Care Med. doi: 10.1097/CCM.0000000000003084 – volume: 4 start-page: 1 year: 2020 ident: 3682_CR34 publication-title: J Am Stat Assoc – volume: 49 start-page: e170 issue: 2 year: 2021 ident: 3682_CR18 publication-title: Crit Care Med. doi: 10.1097/CCM.0000000000004786 – volume: 41 start-page: 472 year: 2013 ident: 3682_CR44 publication-title: Crit Care Med doi: 10.1097/CCM.0b013e31826ab377 – volume: 321 start-page: 2003 year: 2019 ident: 3682_CR21 publication-title: JAMA doi: 10.1001/jama.2019.5791 – volume: 80 start-page: 1 issue: 2 year: 2017 ident: 3682_CR33 publication-title: J Stat Softw. doi: 10.18637/jss.v080.i02 – volume: 321 start-page: 654 year: 2019 ident: 3682_CR3 publication-title: JAMA Am Med Assoc doi: 10.1001/jama.2019.0071 – ident: 3682_CR37 – volume: 50 start-page: 325 year: 2019 ident: 3682_CR55 publication-title: Arch Med Res doi: 10.1016/j.arcmed.2019.10.003 – volume: 110 start-page: 583 year: 2015 ident: 3682_CR24 publication-title: J Am Stat Assoc doi: 10.1080/01621459.2014.937488 – ident: 3682_CR28 doi: 10.1371/journal.pone.0168838 – ident: 3682_CR36 doi: 10.1145/2939672.2939785 – volume: 370 start-page: 1683 year: 2014 ident: 3682_CR2 publication-title: N Engl J Med doi: 10.1056/NEJMoa1401602 – volume: 13 start-page: 301 year: 2020 ident: 3682_CR47 publication-title: J Evid Based Med doi: 10.1111/jebm.12418 – volume: 371 start-page: 1496 year: 2014 ident: 3682_CR10 publication-title: N Engl J Med doi: 10.1056/NEJMoa1404380 – volume: 17 start-page: 109 year: 2016 ident: 3682_CR48 publication-title: BMC Nephrol doi: 10.1186/s12882-016-0323-6 – volume: 8 start-page: 66 year: 2018 ident: 3682_CR42 publication-title: Ann Intensive Care doi: 10.1186/s13613-018-0402-x – volume: 10 start-page: 17874 year: 2020 ident: 3682_CR23 publication-title: Sci Rep doi: 10.1038/s41598-020-74906-z – volume: 24 start-page: 488 issue: 1 year: 2020 ident: 3682_CR53 publication-title: Crit Care. doi: 10.1186/s13054-020-03204-x – volume: 48 start-page: 1645 year: 2020 ident: 3682_CR20 publication-title: Crit Care Med doi: 10.1097/CCM.0000000000004610 – volume: 23 start-page: 1 year: 2019 ident: 3682_CR8 publication-title: Crit Care doi: 10.1186/s13054-019-2411-z |
SSID | ssj0017863 |
Score | 2.4800155 |
Snippet | Background Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify... Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to identify subclasses of... Abstract Background Septic shock comprises a heterogeneous population, and individualized resuscitation strategy is of vital importance. The study aimed to... |
SourceID | doaj pubmedcentral proquest gale crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 1 |
SubjectTerms | Algorithms Blood pressure Care and treatment Clinical medicine Clinical trials Creatinine Critical care Diagnosis Dopamine Dynamic treatment regime Fluid resuscitation Fluid therapy Hospitals Infections Intervention Laboratories Machine learning Methods Mortality Respiratory failure Resuscitation Sepsis Septic shock |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NS-UwEA-LB_Ei6rpYVyULgoelmDRtmh5VFHdBTwreQl4-8IHWZfseqH-9M0lb7Aq7l709XiaQZGYyv2nmg5BDIYJw4CbkjJmQl0ry3AgVQN0xjVGZhln8Dnl1LS9vy5931d27Vl8YE5bKA6eDO2amUWDVbQAvvZTWKawWEzNEpVWhjKl7YPMGZ6p_P6iVFEOKjJLHHdzUVZljOALc2IgpJ2YoVuv_eCf_GSf5zvBcbJD1HjHSk7TSTfLJt1tk9ap_E_9MXn-MOVXzV-8o-M9LsGvpiZ12qfrsCwVwSjsMYbG0u4dLkEa0mqbMYHiO4JM-zp_xSYHGBjlg1ahpHXWpaz0dg9IptnOAH9vk9uL85uwy7zsq5BaQ2SLnDbY-rOB4uHAAHkypvJRBKmxBzCtl5azhoQneFIGXgbnKMctVA04NmwnhxRey0j61fofQSroC2Msq4xVQMuOs8d5UxtUh2NJmhA8HrIc9Y9eLBx3dDiV1YooGpujIFF1n5Ps451cqtvFX6lPk20iJhbLjHyA-uhcf_S_xycgRcl2jOsPyrOmzEmCTWBhLn8i6EAJAo8zI3oQS1NBOhwe50f010OkC69thanKRkW_jMM7E0LbWPy0jDRZxk7iWeiJvk51NR9r5fSwFrgB9AsLf_R9H8ZWsFVFD6pwXe2Rl8Xvp9wFxLWYHUbneAMaYJv4 priority: 102 providerName: Directory of Open Access Journals |
Title | Individualized resuscitation strategy for septic shock formalized by finite mixture modeling and dynamic treatment regimen |
URI | https://www.proquest.com/docview/2552799722 https://www.proquest.com/docview/2551210649 https://pubmed.ncbi.nlm.nih.gov/PMC8273991 https://doaj.org/article/0a98551cf20246cd86560008026c8f49 |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1baxQxFA7agvgiXnG0LhEEHyR0MslkMk_SlZYqtEixsPgSsrnYhTpbO7ug_fWek7noKPRlWTYn7GTOJd9JzoWQN0JE4cFNYHluI5NacWaFjqDumMaobZ07PIc8OVXH5_LTolz0B25tH1Y52MRkqP3a4Rn5foGlwjDLs3h_9YNh1yi8Xe1baNwlu1i6DKW6WowOF6906qTGhZIMtqVySJrRar8F211KhgEKYMMRZU42plS__38r_W_k5F9b0dFD8qDHkPSgY_ojcic0j8m9k_6W_Am5-ThmWa1ugqfgUW9hp-su3Wnb1aP9RQGu0haDWhxtL8As0oRfuylLGF4hHKXfVz_xkoGmljmwz1HbeOq7PvZ0DFOn2OABvjwl50eHXz4cs77HAnOA1TaM19gMsYRXxYUHOGGlDkpFpbEpMS-1U8uaxzoGW0QuY-5Lnzuua3Bz8qUQQTwjO826Cc8JLZUvgOF5aYMGytx6Z0OwpfVVjE66jPDhBZthzdgH49IkR0Qr0zHFAFNMYoqpMvJunHPVld-4lXqOfBspsXR2-mF9_c30mmhyW2uAiS4WAE-U8xrLD6WUY-V0lHVG3iLXDSo4PJ6zfZ4CLBJLZZkDVRUCJEqqjOxNKEEx3XR4kBvTG4bW_BHjjLweh3EmBrs1Yb1NNFjWTeGzVBN5m6xsOtKsLlJxcA14FDD_i9v__CW5XyTZrxgv9sjO5nobXgG62ixnSYVmZHd-ePr5bJbOKODzbP71N55gJdc |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFLZKkYALYhUpBYwE4oCi2lkc54BQWaoZ2umpleZmPF7oSDTTNjOC6Y_iN_Kes0BA6q23UWxn4rzte_FbCHmVpj614CbEjGkfZ1LwWKfSg7hjGqPUJTP4HXJyKEbH2ZdpPt0gv7pcGAyr7HRiUNR2YfAb-U6CpcIwyzN5f3YeY9coPF3tWmg0bLHv1j_AZavfjT8BfV8nyd7no4-juO0qEBtAJ8uYl9j-L-eF5KkFA6oz6YTwQmIbXp5LI2Yl96V3OvE888zmlhkuwTfP2SxNXQr3vUFuguFl6OwV097Bg1uGzm08FVkMZjDvknSk2KnBVuRZjAERYDMQ1Q4MYegX8L9V-DdS8y_Tt3eP3G0xK91tmOw-2XDVA3Jr0p7KPySX4z6ra37pLAUPfgWWtTnkp3VT_3ZNAR7TGoNoDK1PQA3TgJebJTMYniP8pafzn3ioQUOLHrCrVFeW2nWlT2FdHxZPsaEE_HhEjq_l7T8mm9Wick8IzYVNgMFYrp2EmUxbo53TubaF9yYzEeHdC1bdnrHvxncVHB8pVEMUBURRgSiqiMjbfs1ZU-7jytkfkG79TCzVHS4sLr6pVvIV06UEWGp8AnBIGCux3FFIcRZG-qyMyBukukKFAo9ndJsXAZvE0lxqVxRJChyViYhsD2aCIjDD4Y5vVKuIavVHbCLysh_GlRhcV7nFKszBMnICn6UY8NtgZ8ORan4SipFLwL_gY2xd_ecvyO3R0eRAHYwP95-SO0mQgyLmyTbZXF6s3DNAdsvZ8yBOlHy9bvn9DRUAXHY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Individualized+resuscitation+strategy+for+septic+shock+formalized+by+finite+mixture+modeling+and+dynamic+treatment+regimen&rft.jtitle=Critical+care+%28London%2C+England%29&rft.au=Ma%2C+Penglin&rft.au=Liu%2C+Jingtao&rft.au=Shen%2C+Feng&rft.au=Liao%2C+Xuelian&rft.date=2021-07-12&rft.issn=1364-8535&rft.eissn=1364-8535&rft.volume=25&rft.issue=1&rft_id=info:doi/10.1186%2Fs13054-021-03682-7&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s13054_021_03682_7 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1364-8535&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1364-8535&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1364-8535&client=summon |